Bionik Laboratories Corp.
BNKL · OTC
3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
|---|---|---|---|---|
| Market Cap | $2,761 | $2,192 | $12,821 | $8,243 |
| - Cash | $427 | $1,991 | $608 | $2,270 |
| + Debt | $2,412 | $0 | $3,718 | $2,079 |
| Enterprise Value | $4,746 | $200 | $15,931 | $8,052 |
| Revenue | $1,805 | $1,274 | $1,193 | $2,153 |
| % Growth | 41.7% | 6.7% | -44.6% | – |
| Gross Profit | $990 | $953 | $924 | $1,260 |
| % Margin | 54.8% | 74.8% | 77.4% | 58.5% |
| EBITDA | -$4,776 | -$9,480 | -$13,025 | -$24,454 |
| % Margin | -264.6% | -744.3% | -1,091.4% | -1,135.6% |
| Net Income | -$4,946 | -$10,408 | -$13,620 | -$24,935 |
| % Margin | -274% | -817.1% | -1,141.3% | -1,157.9% |
| EPS Diluted | -0.72 | -1.78 | -2.66 | -5.6 |
| % Growth | 59.6% | 33.1% | 52.5% | – |
| Operating Cash Flow | -$3,387 | -$4,147 | -$4,624 | -$9,064 |
| Capital Expenditures | -$9 | -$13 | -$0 | -$160 |
| Free Cash Flow | -$3,387 | -$4,160 | -$4,624 | -$9,223 |